Can contrast-enhanced spectral mammography (cesm) reduce benign breast biopsy?

HIGHLIGHTS

• who: Can Contrast-Enhanced Spectral Mammography and colleagues from the Kong Chian School of Medicine, Nanyang Technological University, Mandalay Road, Singapore have published the paper: Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?, in the Journal: ue020e Breast Journal of 24/03/2022
• what: The authors propose that lesion that is both non-palpable and demonstrates low suspicion for malignancy morphologically (BI-RADS 4A) should be considered for a downgrade to BI-RADS 3 if there is absence of enhancement on CESM.
• how: This study was carried out in a diagnostic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.